VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (4)
A phase 2 study of bortezomib in relapsed, refractory myeloma.
A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients.
Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial.
Survival Outcomes of Patients with Mycosis Fungoides Involving the External Ear and Ear Canal.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A phase 2 study of bortezomib in relapsed, refractory myeloma.
A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med. 2003 Jun 26; 348(26):2609-17.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Boronic Acids
Bortezomib
Cysteine Endopeptidases
Dexamethasone
Dose-Response Relationship, Drug
Drug Therapy, Combination
Female
Hemoglobins
Humans
Male
Middle Aged
Multienzyme Complexes
Multiple Myeloma
Peripheral Nervous System Diseases
Prognosis
Protease Inhibitors
Proteasome Endopeptidase Complex
Pyrazines
Recurrence
authors with profiles
ROBERT ORLOWSKI